tiprankstipranks
Trending News
More News >
Seres Therapeutics Inc. (DE:1S90)
NASDAQ:1S90

Seres Therapeutics (1S90) Revenue

Compare
1 Followers

Seres Therapeutics Revenue

Seres Therapeutics had a revenue of 351.00K in the quarter ending Sep 30, 2025, with Infinity%. This bring the company's revenue in the last twelve months to 351.00K, Decreased Infinity%. In the fiscal year ending Dec 31, 2024, Seres Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
351.00K
Revenue Growth
P/S Ratio
Revenue/Employee
€0
Employees
103
Market Cap
€119.90M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
-144.93M
Dec 31, 2021
144.93M111.71M+436.33%
Dec 31, 2020
33.22M-1.29M+96.26%
Dec 31, 2019
34.51M6.24M+122.07%
Dec 31, 2018
28.27M-3.83M+88.06%
Dec 31, 2017
32.10M10.33M+147.48%
Dec 31, 2016
21.77M